14 Oct 2026, 09:09 IST
Sun Pharmaceutical Industries Limited
Tata Asset Management Pvt. Ltd. (Tata Mutual Fund)
The report notes Sun Pharma approved a plan to raise up to Rs 10,000 crore via NCDs for funding and business expansion.
From TATA MF Daily Market Monitor, written by Tata Asset Management Pvt. Ltd. (Tata Mutual Fund) and hosted by Tata Mutual Fund. Orivam summarised it; the view is Tata Asset Management Pvt. Ltd. (Tata Mutual Fund)'s, not Orivam's.
Open the original PDF on Tata Mutual Fund →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.